Figure 1
From: Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer
The relationship between an inflammation-based prognostic score (GPS, 0, 1, 2 from top to bottom) and survival in patients with metastatic breast cancer.
